Janssen Kaylynn Callister HR Leader Oncology, Janssen Diagnostics, - - PowerPoint PPT Presentation

janssen
SMART_READER_LITE
LIVE PREVIEW

Janssen Kaylynn Callister HR Leader Oncology, Janssen Diagnostics, - - PowerPoint PPT Presentation

Janssen Kaylynn Callister HR Leader Oncology, Janssen Diagnostics, Discovery Sciences Todays Agenda Goal is to help you become aware of what we do; who we are; and what we believe in Introductions Intro to J&J and Janssen


slide-1
SLIDE 1

Janssen

Kaylynn Callister

HR Leader Oncology, Janssen Diagnostics, Discovery Sciences

slide-2
SLIDE 2

Today’s Agenda

Goal is to help you become aware of what we do; who we are; and what we believe in

  • Introductions
  • Intro to J&J and Janssen
  • Panel of PhD employees
  • Q&A and Networking

2

slide-3
SLIDE 3

New Hire Toolkit | Slides Effective February, 2016 | Confidential | 3

Our History

What year was Johnson & Johnson founded?

  • Dr. Joseph Lister
slide-4
SLIDE 4

New Hire Toolkit | Slides Effective February, 2016 | Confidential | 4

  • https://www.youtube.com/watch?v=r4-5OrdtXpI

4

slide-5
SLIDE 5

New Hire Toolkit | Slides Effective February, 2016 | Confidential | 5

Our Credo Drives Our Success

“I am resolute in my determination to keep Our Credo as the foundation

  • f Johnson & Johnson. Our Credo

has long been – and must continue to be – the defining feature of our organization, because it reflects our core value system, our beliefs and

  • ur aspirations.”

–Alex Gorsky

5

slide-6
SLIDE 6

New Hire Toolkit | Slides Effective February, 2016 | Confidential | 6

6

slide-7
SLIDE 7

New Hire Toolkit | Slides Effective February, 2016 | Confidential | 7

About the Company

BUSINESS STRUCTURE

Consumer Medical Devices Pharmaceuticals

slide-8
SLIDE 8

New Hire Toolkit | Slides Effective February, 2016 | Confidential | 8

§ Therapeutic Areas § Immunology § Neuroscience § Infectious Diseases/

Vaccines

§ Oncology § Cardiovascular &

Metabolism/Other

§ Vision Care/ Diabetes § Global Surgery § Surgical Care § Specialty Surgery § Infection Prevention § Cardiovascular Care § Global Orthopedics § Diagnostics

Pharmaceuticals Medical Devices Consumer

§ Baby § Skin Care § Oral care § Women’s Health § Wound Care § OTC/Nutritionals

—

Consumer – Products marketed to the general public and sold both to retail outlets and distributors.

—

Pharmaceuticals – Products distributed directly to retailers, wholesalers, and health care professionals for prescription use.

—

Medical Devices – Products distributed to wholesalers, hospitals, and retailers used principally in the professional field by physicians, nurses, therapists, hospitals, diagnostic laboratories, and clinics.

About the Company

BUSINESS STRUCTURE – SEGMENTS

slide-9
SLIDE 9

9

What are some of the original drug discoveries Dr. Paul Janssen made?

slide-10
SLIDE 10

10

slide-11
SLIDE 11

11

slide-12
SLIDE 12

Janssen – Creating Value Through Innovation

  • Leader in productivity, FDA approvals, breakthrough

designations

  • 14 new products since 2009
  • Most FDA approvals 2009-2014
  • One of the fastest growing top-ten pharmaceutical

companies

  • Most admired pharmaceutical company

12

slide-13
SLIDE 13

13

slide-14
SLIDE 14

14

slide-15
SLIDE 15

15

slide-16
SLIDE 16

16

slide-17
SLIDE 17

17

slide-18
SLIDE 18

$28.1B +12.0%

Huge Medical Need

18

slide-19
SLIDE 19

19

slide-20
SLIDE 20

20

slide-21
SLIDE 21

21

slide-22
SLIDE 22

22

slide-23
SLIDE 23

23

slide-24
SLIDE 24

24

slide-25
SLIDE 25

25

2 5

slide-26
SLIDE 26

Introduction to our Panel

3-4pm 4-5pm Q&A Networking

Name Title Department Email Naushad Islam

  • Sr. Director, Global

Regulatory Global Regulatory Organization nislam@its.jnj.com Anne Vosatka VP, Compound Development Team Leader Cardiovascular & Metabolics avosatka@its.jnj.com John Fastenau Team Leader, Real World Evidence Real World Evidence jfastena@its.jnj.com Daniel Weinstock

  • Sr. Director,

Immunopathology Toxicology Janssen Biotherapeutics dweinsto@its.jnj.com Homer Adams

  • Sr. Scientist

Oncology hadamsii@its.jnj.com Brent Rupnow Director, Prostate Discovery Oncology brupnow@its.jnj.com Nishan Sengupta Global Market Access Leader Oncology nsengupt@its.jnj.com Doris Forestal Director, TA Head Global Labeling Oncology/CVM Oncology/CVM dforesta@its.jnj.com Samantha Allen

  • Sr. Scientist

Screening sallen37@its.jnj.com

26